Search Results

You are looking at 1 - 1 of 1 items for

  • Author: M. Errington x
Clear All Modify Search
Restricted access

G. Caldwell, M. Errington and A. D. Toft

Abstract. Sodium iopodate has recently been advocated for long-term control of hyperthyroidism in Graves' disease. Its advantages over conventional therapy are a rapid fall in thyroid hormones and control of symptoms with a simple dosage regime. We report a case in which severe resistant hyperthyroidism developed during treatment of Graves' disease with sodium iopodate. Sodium iopodate may not be suitable for long-term use in all patients with Graves' disease.